Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

S1929, Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC) (273385)


Collapse Overview 
Collapse sponsor award id
S1929


Collapse Biography 

Collapse Time 
Collapse start date
2021-09-24

Collapse end date
2031-09-23